A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis

Davidson, Michael; D. Harvey, Philip; Vervarcke, J.; A. Gagiano, C.; D. De Hooge, J.; Bray, Gary; Dose, M.; Barak, Yoram; Haushofer, M.

doi:10.1002/1099-1166(200006)15:6<506::aid-gps146>3.0.co;2-v

Public

A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis

Published in International Journal of Geriatric Psychiatry • Jan 1, 2000

Authors:

Michael Davidson

Philip D. Harvey

J. Vervarcke

Abstract

RATIONALE: Studies have shown that risperidone is safe and efficacious in young and middle-aged adults with chronic schizophrenia, but considerably fewer data are available on the treatment of elderly patients with schizophrenia or other psychotic disorders, particularly long-term outcomes. OBJECTIV...

Subject

Risperidone

Extrapyramidal symptoms

Tardive dyskinesia

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!